8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Quest Diagnostics ($DGX) will present on strategy, performance and market trends at the 44th Annual J.P.
Filed with the SEC on · Summarized by InvestorsBot
Quest Diagnostics ($DGX) will present on strategy, performance and market trends at the 44th Annual J.P. Morgan Healthcare Conference on Jan 12, 2026 — presentation + Q&A. 🎙️📈 #Healthcare #Investing
Presentation materials are furnished as Exhibit 99.1 to Quest Diagnostics’ Form 8‑K (Item 7.01) — included for Reg FD disclosure but not “filed” under the Exchange Act. 📄 $DGX #SEC #RegFD
Materials include forward‑looking statements; management warns not to place undue reliance. Key risks cited: economic conditions, litigation, reimbursement complexity, competition and other factors in DGX’s 10‑K/10‑Q filings. ⚠️ $DGX #Risk #Investing